1-3 of 3
Bronwyn Moore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient Characteristics, Treatment Patterns and Early Outcomes of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Initiated on Talquetamab: An Electronic Medical Record and Chart Review Study

Cesar Rodriguez, Hsien-Yen Chang, Yi-Hsuan Liu, Jinghua He, Hoa H. Le, Jessica Maitland, Alvi A. Rahman, Anabelle Tardif-Samson, Bronwyn Moore, Marie-Hélène Lafeuille, Saurabh N. Patel, Xinke Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 5157.
https://doi.org/10.1182/blood-2024-203735
Published: 2024
Journal Articles

Comparison of Time to Next Treatment or Death between Front-Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) and Bortezomib, Lenalidomide, and Dexamethasone (VRd) in Transplant Ineligible Patients with Multiple Myeloma

Doris K. Hansen, Santosh Gautam, Marie-Hélène Lafeuille, Carmine Rossi, Bronwyn Moore, Anabelle Tardif-Samson, Philippe Thompson-Leduc, Alex Z. Fu, Annelore Cortoos, Shuchita Kaila, Rafael Fonseca
Journal: Blood
Blood (2023) 142 (Supplement 1): 543.
https://doi.org/10.1182/blood-2023-187233
Published: 2023
Journal Articles

Ibrutinib Dose Adjustment Does Not Impact Time to Next Treatment in First-Line Patients with Chronic Lymphocytic Leukemia: A Real-World Analysis of Electronic Medical Records from Academic and Non-Teaching Hospitals Using Target Trial Emulation

Nilanjan Ghosh, Zaina P Qureshi, Zhijie Ding, Marie-Helene Lafeuille, Bruno Emond, Priyanka Gogna, Bronwyn Moore, Patrick Lefebvre, Alex Bokun, Heena Mavani, Kerry A Rogers
Journal: Blood
Blood (2023) 142 (Supplement 1): 1915.
https://doi.org/10.1182/blood-2023-186284
Published: 2023